Involvement of MAP kinase and c-fos signaling in the inhibition of cell growth by somatostatin

American Journal of Physiology - Endocrinology and Metabolism

Volumn 272, Issue 5 35-5, 1997, Pages

  Yoshitomi, Hideyuki ^a   Fujii, Yasukazu ^a,b   Miyazaki, Masaru ^a   Nakajima, Nobuyuki ^a   Inagaki, Nobuya ^a   Seino, Susumu ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

endocrine tumor; G protein; immediate early genes; mitogen activated protein kinase; tyrosine kinase

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PERTUSSIS TOXIN; SOMATOSTATIN;

ANIMAL CELL; ARTICLE; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVITY; GROWTH INHIBITION; IMMEDIATE EARLY GENE; MOUSE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0030922670     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1997.272.5.e769     Document Type: Article

References (35)

1. 2+ mobilization by cloned human somatostatin receptor subtypes 1-5, in transfected COS-7 cells. FEBS Lett. 348: 192-196, 1994.
2. Bito, H., M. Mori, C. Sakanaka, T. Takano, Z. I. Honda, Y. Gotoh, E. Nishida, and T. Shimizu. Functional coupling of SSTR4, a major hippocampal somatostatin receptor, to adenylate cyclase inhibition, arachidonate release, and activation of the mitogen-activated protein kinase cascade. J. Biol. Chem. 269: 12722-12730, 1994.
3. Brazeau, P., W. Vale, R. Burgus, N. Ling, M. Butcher, J. Rivier, and R. Guillemin. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179: 77-79, 1973.
4. Buscail, L., N. Delesque, J.-P. Estève, N. Saint-Laurent, H. Prats, P. Clerc, P. Robberecht, G. I. Bell, C. Liebow, A. V. Shally, N. Vaysse, and C. Susini. Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2. Proc. Natl. Acad. Sci. USA 91: 2315-2319, 1994.
5. Buscail, L., J.-P. Estève, N. Saint-Laurent, V. Bertrand, T. Reisine, A.-M. O'Carroll, G. I. Bell, A. V. Shally, N. Vaysse, and C. Susini. Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms. Proc. Natl. Acad. Sci. USA 92: 1580-1584, 1995.
6. 3 rat pituitary tumor cell proliferation via a transient G0/G1 cell cycle block. Endocrinology 136: 4174-4181, 1995.
7. Crespo, P., N. Xu, W. F. Simonds, and J. S. Gutkind. Ras-dependent activation of MAP kinase pathway mediated by G-protein βγ subunits. Nature 369: 418-420, 1994.
8. Fujii, Y., T. Gonoi, Y. Yamada, K. Chihara, N. Inagaki, and S. Seino. Somatostatin receptor subtype SSTR2 mediates the inhibition of high-voltage-activated calcium channels by somatostatin and its analogue. FEBS Lett. 355: 117-120, 1994.
9. TCF by MAP kinase stimulates ternary complex formation at c-fos promoter. Nature 358: 414-417, 1992.
10. Hunter, T. Protein kinases and phosphatases: the Yin and Yang of protein phosphorylation and signaling. Cell 80: 225-236, 1995.
11. ras. Proc. Natl. Acad. Sci. USA 91: 12706-12710, 1994.
12. Kovary, K., and R. Bravo. The jun and fos protein families are both required for cell cycle progression in fibroblasts. Mol. Cell. Biol. 11: 4466-4472, 1991.
13. Kubota, A., Y. Yamada, S. Kagimoto, A. Shimatsu, M. Imamura, K. Tsuda, H. Imura, S. Seino, and Y. Seino. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors. J. Clin. Invest. 93: 1321-1325, 1994.
14. Lamberts, S. W. J., E. P. Krenning, and J.-C. Reubi. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr. Rev. 12: 450-482, 1991.
15. iα1 selectively couples somatostatin receptor subtype 3 to adenylyl cyclase: identification of the functional domains of this α subunit necessary for mediating the inhibition by somatostatin of cAMP formation. Mol. Pharmacol. 45: 587-590, 1994.
16. Liebow, C., C. Reilly, M. Serrano, and A. V. Shally. Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase. Proc. Natl. Acad. Sci. USA 86: 2003-2007, 1989.
17. Miyazaki, J. I., K.Araki, E. Yamato, H. Ikegami, T. Asano, Y. Shibasaki, Y. Oka, and K. I. Yamamura. Establishment of a pancreatic β cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology 127: 126-132, 1990.
18. Pagliacci, M. C., R. Tognellini, F. Grignani, and I. Nicoletti. Inhibition of human breast cancer cell (MCF-7) growth in vitro by the somatostatin analog SMS201-995: effects on cell cycle parameters and apoptotic cell death. Endocrinology 129: 2555-2562, 1991.
19. Pan, M. G., T. Florio, and P. J. S. Stork. G protein activation of a hormone-stimulated phosphatase in human tumor cells. Science 256: 1215-1217, 1992.
20. Reichlin, S. Somatostatin (part I). N. Engl. J. Med. 309: 1495-1501, 1983.
21. Reichlin, S. Somatostatin (part II). N. Engl. J. Med. 309: 1556-1563, 1983.
22. Reisine, T., and G. I. Bell. Molecular biology of somatostatin receptors. Endocr. Rev. 16: 427-442, 1995.
23. Reubi, J.-C., and J. A. Laissue. Multiple actions of somatostatin in neoplastic disease. Trends Pharmacol. Sci. 16: 110-115, 1995.
24. Riabowol, K. T., R. J. Vosatka, E. B. Ziff, N. J. Lamb, and J. R. Feramisco. Microinjection of fos-specific antibodies blocks DNA synthesis in fibroblast cells. Mol. Cell. Biol. 8: 1670-1676, 1988.
25. Schonbrunn, A., and A. H. Tashjian, Jr. Characterization of functional receptors for somatostatin in rat pituitary cells in culture. J. Biol. Chem. 253: 6473-6483, 1978.
26. Seshadri, T., and J. Campisi. Repression of c-fos transcription and an altered genetic program in senescent human fibroblasts. Science 247: 205-209, 1990.
27. Setyono-Han, B., M. S. Henkelman, J. A. Foekens, and J. G. M. Klijn. Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells. Cancer Res. 47: 1566-1570, 1987.
28. Shally, A. V. Oncological applications of somatostatin analogues. Cancer Res. 48: 6977-6985, 1988.
29. Todisco, A., V. Campbell, C. J. Dickison, J. DelValle, and T. Yamada. Molecular basis for somatostatin action: inhibition of c-fos expression and AP-1 binding. Am. J. Physiol. 267 (Gastrointest. Liver Physiol. 30): G245-G253, 1994.
30. Todisco, A., C. Seva, Y. Takeuchi, C. J. Dickison, and T. Yamada. Somatostatin inhibits AP-1 function via multiple protein phosphatases. Am. J. Physiol. 269 (Gastrointest. Liver Physiol. 32): G160-G166, 1995.
31. Treisman, R. Journey to the surface of the cell: fos regulation and SRE. EMBO J. 14: 4905-4913, 1995.
32. Yamada, Y., S. Kagimoto, A. Kubota, K. Yasuda, K. Masuda, Y. Someya, Y. Ihara, Q. Li, H. Imura, S. Seino, and Y. Seino. Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and a fifth (hSSTR5) human somatostatin receptor subtype. Biochem. Biophys. Res. Commun. 195: 844-852, 1993.
33. Yamada, Y., S. R. Post, K. Wang, H. S. Tager, G. I. Bell, and S. Seino. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc. Natl. Acad. Sci. USA 89: 251-255, 1992.
34. Yamada, Y., T. Reisine, S. F. Law, Y. Ihara, A. Kubota, S. Kagimoto, M. Seino, Y. Seino, G. I. Bell, and S. Seino. Somatostatin receptors, an expanding gene family: cloning and functional characterization of human SSTR3, a protein coupled to adenylyl cyclase. Mol. Endocrinol. 6: 2136-2142, 1992.
35. Wan, Y., T. Kurosaki, and X. Y. Huang. Tyrosine kinases in activation of the MAP kinase cascade by G-protein-coupled receptors. Nature 380: 541-544, 1996.